Immediate Impact
49 standout
Citing Papers
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
2025 Standout
evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
2025 Standout
Works of Aditya Raju being referenced
Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Aditya Raju | 181 | 152 | 136 | 286 | 157 | 40 | 722 | |
| Miny Samuel | 101 | 40 | 92 | 201 | 48 | 32 | 638 | |
| J. Porter | 28 | 57 | 112 | 261 | 62 | 43 | 665 | |
| Sheikh Usman Iqbal | 139 | 161 | 175 | 150 | 56 | 30 | 652 | |
| O Schweizer | 40 | 63 | 62 | 231 | 41 | 57 | 693 | |
| Peter H. Norman | 46 | 45 | 51 | 316 | 203 | 36 | 710 | |
| Nicole R. Guinn | 122 | 56 | 11 | 253 | 36 | 36 | 717 | |
| Kimberly Noonan | 85 | 93 | 194 | 442 | 67 | 19 | 788 | |
| Hilde Pleym | 76 | 36 | 23 | 348 | 103 | 37 | 774 | |
| Jens Fromholt Larsen | 30 | 56 | 47 | 293 | 33 | 34 | 666 | |
| Erik D. Peltz | 42 | 193 | 31 | 158 | 30 | 34 | 827 |
All Works
Login with ORCID to disown or claim papers
Loading papers...